Grifols GRFS Peer Comparison

NASDAQ GRFS
$7.68 -0.14 (-1.85%)
As of: Sep 10, 2026 · 3:24 PM EDT
Peer Comparison

300 Comparable Companies

Industry Biotechnology

The table below compares all 300 Biotechnology companies on 8 financial metrics.

Download Data
# Ticker Company match industry_code industry_group industry_group_code Market Capitalization P/E P/S Enterprise Value
1 AMGN Amgen Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 206.74 Bn 23.65 5.43 192.75 Bn
2 GILD Gilead Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 179.96 Bn -62.16 5.91 176.78 Bn
3 VRTX Vertex Pharmaceuticals Inc / Ma primary H-02 Pharmaceuticals and Biotechnology HG-01 131.20 Bn 29.78 10.42 123.35 Bn
4 REGN Regeneron Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 82.05 Bn 18.95 5.28 74.05 Bn
5 ARGX Argenx Se primary H-02 Pharmaceuticals and Biotechnology HG-01 60.28 Bn 35.14 11.54 55.10 Bn
6 MRNA Moderna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 53.67 Bn -17.03 24.09 48.54 Bn
7 ALNY Alnylam Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 33.08 Bn 42.71 6.89 29.78 Bn
8 BIIB Biogen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 31.91 Bn 38.23 3.18 30.62 Bn
9 ROIV Roivant Sciences Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 29.22 Bn -19.69 2,675.45 29.22 Bn
10 INSM INSMED Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 27.59 Bn -31.52 24.25 26.43 Bn
11 BNTX BioNTech SE primary H-02 Pharmaceuticals and Biotechnology HG-01 23.18 Bn -13.60 7.49 9.52 Bn
12 ASND Ascendis Pharma A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 15.74 Bn 18.16 11.10 14.80 Bn
13 MDGL Madrigal Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 15.23 Bn -47.75 11.86 14.39 Bn
14 BBIO BridgeBio Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 14.21 Bn -20.53 19.92 13.49 Bn
15 SMMT Summit Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 13.14 Bn — — 12.45 Bn
16 BMRN Biomarin Pharmaceutical Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 12.63 Bn 173.07 3.71 11.76 Bn
17 HALO Halozyme Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 12.53 Bn 30.30 7.53 12.30 Bn
18 ARWR Arrowhead Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 11.88 Bn -43.65 17.74 10.28 Bn
19 AAVXF Abivax S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.92 Bn -25.97 — 10.92 Bn
20 APGE Apogee Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 10.18 Bn -34.62 — 9.20 Bn
21 PRAX Praxis Precision Medicines, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 9.84 Bn -25.81 — 9.09 Bn
22 PTGX Protagonist Therapeutics, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.50 Bn 86.04 33.69 9.50 Bn
23 IONS Ionis Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 9.13 Bn -43.04 10.45 7.08 Bn
24 PCVX Vaxcyte, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.47 Bn -8.01 — 8.47 Bn
25 IBRX ImmunityBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 8.15 Bn -8.21 49.15 7.79 Bn
26 IMVT Immunovant, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.79 Bn -14.47 — 7.79 Bn
27 TGTX Tg Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.78 Bn 17.61 9.73 7.10 Bn
28 GIFLF Grifols SA primary H-02 Pharmaceuticals and Biotechnology HG-01 7.54 Bn 29.70 0.46 9.09 Bn
29 SYRE Spyre Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.45 Bn -41.66 — 7.45 Bn
30 SRRK Scholar Rock Holding Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 7.23 Bn -17.92 — 7.23 Bn
31 RYTM Rhythm Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 7.02 Bn -33.37 29.24 6.68 Bn
32 MIRM Mirum Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.35 Bn -7.38 10.27 5.91 Bn
33 CGON CG Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.32 Bn -28.20 1,014.98 6.32 Bn
34 BLRX BioLineRx Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 6.28 Bn -700.77 4,508.69 6.28 Bn
35 KNSA Kiniksa Pharmaceuticals International, plc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.90 Bn 73.17 7.02 5.38 Bn
36 XENE Xenon Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.82 Bn -16.05 — 5.82 Bn
37 LGND Ligand Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 5.80 Bn 29.43 19.98 4.45 Bn
38 COGT Cogent Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.79 Bn -15.65 — 5.79 Bn
39 ORKA Oruka Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.76 Bn — — 4.03 Bn
40 DBVT DBV Technologies S.A. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.62 Bn -31.95 1,120.33 5.45 Bn
41 PTCT Ptc Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 5.59 Bn 14.61 5.54 3.36 Bn
42 ERAS Erasca, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.99 Bn -17.39 — 4.99 Bn
43 CELC Celcuity Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.69 Bn -21.40 — 4.69 Bn
44 DNLI Denali Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 4.00 Bn -7.82 1,109.13 4.00 Bn
45 DNTH Dianthus Therapeutics, Inc. /DE/ primary H-02 Pharmaceuticals and Biotechnology HG-01 3.97 Bn — — 3.56 Bn
46 TLPPF Telix Pharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 3.89 Bn -521.64 4.64 3.59 Bn
47 RLAY Relay Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.85 Bn -13.46 371.89 3.85 Bn
48 VKTX Viking Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.75 Bn -7.02 — 3.75 Bn
49 AMLX Amylyx Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.57 Bn -29.34 — 3.57 Bn
50 TNGX Tango Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.54 Bn -34.56 65.73 2.52 Bn
51 IDYA IDEAYA Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.47 Bn -15.76 14.82 2.64 Bn
52 RCUS Arcus Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.34 Bn -7.26 28.54 2.64 Bn
53 ABCL AbCellera Biologics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.21 Bn -19.49 48.48 3.21 Bn
54 ARQT Arcutis Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.06 Bn 107.43 6.60 2.82 Bn
55 DYN Dyne Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.03 Bn -5.86 — 3.03 Bn
56 CLDX Celldex Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 3.00 Bn -9.76 18,987.05 3.00 Bn
57 MBX MBX Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.94 Bn -28.20 — 2.94 Bn
58 IMNM Immunome Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.86 Bn -10.56 593.06 2.34 Bn
59 IRON Disc Medicine, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.86 Bn -14.18 — 2.86 Bn
60 NRIX Nurix Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.85 Bn -8.36 77.62 2.41 Bn
61 ZLAB Zai Lab Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.71 Bn -14.42 6.04 2.01 Bn
62 SLS SELLAS Life Sciences Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.57 Bn -79.29 — 2.57 Bn
63 VERA Vera Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.40 Bn -6.00 — 2.40 Bn
64 OCUL Ocular Therapeutix, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.39 Bn -7.90 45.96 2.39 Bn
65 XTLB Xtl Biopharmaceuticals Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 2.38 Bn -2,975.41 — 2.38 Bn
66 NKTR Nektar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 2.35 Bn -19.81 43.11 1.67 Bn
67 VRDN Viridian Therapeutics, Inc.\DE primary H-02 Pharmaceuticals and Biotechnology HG-01 2.32 Bn -5.79 32.59 2.32 Bn
68 PHVS Pharvaris N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.23 Bn -11.21 — 1.86 Bn
69 ADMA Adma Biologics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.15 Bn 12.93 4.20 2.02 Bn
70 URGN UroGen Pharma Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.12 Bn -34.03 11.23 2.01 Bn
71 BCRX Biocryst Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 2.11 Bn -5.49 3.95 1.76 Bn
72 GMAB Genmab A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 2.09 Bn 0.17 0.33 0.59 Bn
73 KOD Kodiak Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.08 Bn -8.61 — 2.08 Bn
74 RAPP Rapport Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.05 Bn -14.97 102.70 2.05 Bn
75 AGIO Agios Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 2.00 Bn -4.85 20.29 2.00 Bn
76 BHVN Biohaven Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -3.35 — 1.70 Bn
77 ZBIO Zenas BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.96 Bn -4.72 1,960.90 1.96 Bn
78 ZYME Zymeworks Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.94 Bn -12.96 52.38 1.67 Bn
79 STOK Stoke Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.93 Bn -9.30 70.07 1.64 Bn
80 CMPS COMPASS Pathways plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.90 Bn -4.83 — 1.90 Bn
81 XNCR Xencor Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.84 Bn -11.26 17.51 1.46 Bn
82 VIR Vir Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.79 Bn -7.11 5.90 1.79 Bn
83 GLPGF Lakefront Biotherapeutics NV primary H-02 Pharmaceuticals and Biotechnology HG-01 1.73 Bn 0.00 1.50 1.73 Bn
84 INBX Inhibrx Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.72 Bn -12.87 1,320.41 1.72 Bn
85 IMCR Immunocore Holdings plc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.71 Bn -94.22 3.96 0.83 Bn
86 SEPN Septerna, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.70 Bn -121.84 17.20 1.70 Bn
87 RXRX Recursion Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.69 Bn -3.26 30.82 1.14 Bn
88 SNDX Syndax Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.67 Bn -9.19 6.60 1.12 Bn
89 GHRS GH Research PLC primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -26.52 — 1.29 Bn
90 DMRA Damora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.65 Bn -6.27 — 1.11 Bn
91 ATAI AtaiBeckley Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.60 Bn -10.37 525.54 1.60 Bn
92 FBRX Forte Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -20.71 — 1.23 Bn
93 BCAX Bicara Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.58 Bn -8.51 — 1.58 Bn
94 ANAB Anaptysbio, Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.57 Bn -65.89 7.90 1.29 Bn
95 TYRA Tyra Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.54 Bn -10.35 — 1.54 Bn
96 NVAX Novavax Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.53 Bn -6.17 3.69 0.81 Bn
97 SCNI Scinai Immunotherapeutics Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.52 Bn -181.27 881.72 1.52 Bn
98 AAPG Ascentage Pharma Group International primary H-02 Pharmaceuticals and Biotechnology HG-01 1.49 Bn -9.11 20.12 1.21 Bn
99 RARE Ultragenyx Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.46 Bn -3.15 2.03 1.16 Bn
100 MAZE Maze Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.45 Bn -13.63 72.30 1.45 Bn
101 GLUE Monte Rosa Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.44 Bn -9.34 50.06 0.81 Bn
102 AVBP ArriVent BioPharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.36 Bn -8.33 — 1.36 Bn
103 ANRO Alto Neuroscience, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.35 Bn -16.16 — 1.35 Bn
104 OMER Omeros Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.34 Bn 78.23 34.75 1.34 Bn
105 SVRA Savara Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 1.33 Bn -9.58 — 1.33 Bn
106 ORIC Oric Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.31 Bn -8.35 — 1.31 Bn
107 REPL Replimune Group, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -4.39 — 1.30 Bn
108 CGEM Cullinan Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.30 Bn -6.37 — 1.30 Bn
109 ABSI Absci Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.27 Bn -10.47 812.07 1.07 Bn
110 ALMS Alumis Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.26 Bn -5.22 151.89 0.76 Bn
111 VOR Vor Biopharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.22 Bn -1.32 — 1.22 Bn
112 CRVS Corvus Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.20 Bn -25.15 — 0.99 Bn
113 JBIO Jade Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -7.64 — 1.17 Bn
114 MNKD Mannkind Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.17 Bn -26.80 2.97 1.06 Bn
115 CLYM Climb Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.14 Bn -19.78 — 1.14 Bn
116 JANX Janux Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 1.12 Bn -10.88 46.52 1.12 Bn
117 ABUS Arbutus Biopharma Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 1.01 Bn 6.62 5.55 0.92 Bn
118 MLTX MoonLake Immunotherapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.98 Bn -3.69 — 0.44 Bn
119 OKYO OKYO Pharma Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.97 Bn -118.02 — 0.97 Bn
120 WVE Wave Life Sciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.96 Bn -4.74 14.68 0.59 Bn
121 MNPR Monopar Therapeutics primary H-02 Pharmaceuticals and Biotechnology HG-01 0.94 Bn -68.10 — 0.89 Bn
122 GERN Geron Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.91 Bn -13.59 3.75 0.61 Bn
123 ARDX Ardelyx, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.90 Bn -16.23 2.01 0.62 Bn
124 TBPH Theravance Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.88 Bn 20.81 8.44 0.49 Bn
125 RIGL Rigel Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.87 Bn 2.70 3.14 0.77 Bn
126 ANNX Annexon, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.83 Bn -4.04 — 0.83 Bn
127 STTK Shattuck Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.81 Bn -14.95 807.23 0.81 Bn
128 ACRS Aclaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.79 Bn -9.87 95.60 0.79 Bn
129 AVTX Avalo Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.76 Bn -7.58 — 0.76 Bn
130 CTMX CytomX Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -9.77 40.49 0.41 Bn
131 PHAR Pharming Group N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.74 Bn -118.96 2.22 0.58 Bn
132 ZURA Zura Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.69 Bn -5.92 — 0.69 Bn
133 AURA Aura Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.66 Bn -6.04 — 0.59 Bn
134 IRWD Ironwood Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.65 Bn 2.96 1.68 0.57 Bn
135 SLN Silence Therapeutics plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.63 Bn -16.25 1,026.92 0.56 Bn
136 ALT Altimmune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.61 Bn -8.22 — 0.61 Bn
137 CBIO Crescent Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.60 Bn -3.68 577.29 0.43 Bn
138 OCS Oculis Holding AG primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -337,225.82 — 0.59 Bn
139 SGMT Sagimet Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.59 Bn -12.25 — 0.59 Bn
140 ASMB Assembly Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.58 Bn 466.26 7.75 0.26 Bn
141 VALN Valneva SE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.57 Bn -9.69 3.39 0.42 Bn
142 ARVN Arvinas, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn 60.45 1.77 -0.01 Bn
143 CTNM Contineum Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.56 Bn -9.24 — 0.56 Bn
144 TECX Tectonic Therapeutic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.55 Bn -6.43 — 0.55 Bn
145 OABI OmniAb, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -11.56 13.31 0.46 Bn
146 IMUX Immunic, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.51 Bn -4.39 — 0.51 Bn
147 ANL Adlai Nortye Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.50 Bn -10.27 78.36 0.27 Bn
148 PRLD Prelude Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -7.02 21.10 0.19 Bn
149 PRTA Prothena Corp Public Ltd Co primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn -10.75 8.65 0.18 Bn
150 PBYI Puma Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.47 Bn 15.59 2.02 0.37 Bn
151 NEUP Neuphoria Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn -19.62 — 0.45 Bn
152 KMDA Kamada Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.46 Bn 14.81 2.40 0.39 Bn
153 RLMD Relmada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -7.41 — 0.45 Bn
154 BBOT BridgeBio Oncology Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -2.28 — 0.23 Bn
155 DRUG Bright Minds Biosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.45 Bn -15.44 — 0.45 Bn
156 CCCC C4 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.44 Bn -4.34 12.55 0.19 Bn
157 RZLT Rezolute, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.43 Bn -5.32 — 0.43 Bn
158 AVIR Atea Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.42 Bn -3.07 — 0.42 Bn
159 ARCT Arcturus Therapeutics Holdings Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -4.25 13.78 0.21 Bn
160 LRMR Larimar Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.40 Bn -2.26 — 0.24 Bn
161 EVMN Evommune, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.14 39.15 0.19 Bn
162 BIOA BioAge Labs, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.39 Bn -4.13 37.41 0.39 Bn
163 CMPX Compass Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn -4.72 — 0.38 Bn
164 HMDCF HUTCHMED (China) Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.38 Bn — — 0.39 Bn
165 EYPT EyePoint, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -1.19 131.57 0.19 Bn
166 ENTA Enanta Pharmaceuticals Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.37 Bn -5.80 5.61 0.18 Bn
167 DMAC DiaMedica Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.34 Bn -10.42 — 0.34 Bn
168 CATX Perspective Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -2.79 — 0.33 Bn
169 WHWK Whitehawk Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.33 Bn -4.15 — 0.33 Bn
170 EPRX Eupraxia Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -6.39 — 0.32 Bn
171 FHTX Foghorn Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -4.84 8.64 0.25 Bn
172 UPB Upstream Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -1.98 100.39 0.32 Bn
173 ELDN Eledon Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.32 Bn -3.81 — 0.32 Bn
174 STRO Sutro Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn -2.60 3.28 0.13 Bn
175 AGEN Agenus Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.29 Bn 3.11 2.15 0.29 Bn
176 TRDA Entrada Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.28 Bn -1.67 58.93 0.28 Bn
177 SABS SAB Biotherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -3.98 — 0.27 Bn
178 EQ Equillium, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -15.17 — 0.27 Bn
179 ACIU AC Immune SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -4.99 12.19 0.27 Bn
180 BCYC Bicycle Therapeutics Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.27 Bn -1.41 4.39 0.27 Bn
181 ANTX AN2 Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -7.16 — 0.26 Bn
182 GALT Galectin Therapeutics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.26 Bn -9.19 — 0.26 Bn
183 ALXO Alx Oncology Holdings Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -3.11 — 0.25 Bn
184 IVVD Invivyd, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -2.99 4.47 0.09 Bn
185 MGNX Macrogenics Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -15.60 1.50 0.14 Bn
186 CAMP Camp4 Therapeutics Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -4.98 59.08 0.25 Bn
187 FIXX Q32 Bio Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn 61.72 — 0.14 Bn
188 AVXL Anavex Life Sciences Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.25 Bn -17.53 — 0.13 Bn
189 CYDY CytoDyn Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.24 Bn -7.15 — 0.24 Bn
190 ALEC Alector, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.66 16.85 0.06 Bn
191 SRZN Surrozen, Inc./DE primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -3.79 20.09 0.23 Bn
192 CGEN Compugen Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn 6.53 3.11 0.14 Bn
193 KRRO Korro Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.23 Bn -2.75 95.53 0.11 Bn
194 FTH Faeth Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -1.14 — 0.22 Bn
195 KROS Keros Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -2.45 6.72 -0.04 Bn
196 GLSI Greenwich LifeSciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn -9.90 — 0.22 Bn
197 PLX Protalix BioTherapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.22 Bn 10.29 2.70 0.18 Bn
198 NMRA Neumora Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.29 — 0.21 Bn
199 CHRS Coherus Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -1.58 4.10 0.10 Bn
200 PEPG PepGen Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -2.89 — 0.21 Bn
201 PYXS Pyxis Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.21 Bn -3.12 14.87 0.17 Bn
202 ABOS Acumen Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -1.96 — 0.20 Bn
203 PRQR ProQR Therapeutics N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -4.14 9.51 0.07 Bn
204 ORMP Oramed Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn 1.15 — 0.20 Bn
205 ADAG Adagene Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.20 Bn -13.14 32.66 0.20 Bn
206 ARMP Armata Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -3.04 — 0.16 Bn
207 NBP NovaBridge Biosciences primary H-02 Pharmaceuticals and Biotechnology HG-01 0.19 Bn -2.47 — 0.19 Bn
208 CUE Cue Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -1.77 7.98 0.16 Bn
209 QNCX Quince Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.18 Bn -2.33 — 0.18 Bn
210 XLO Xilio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -5.56 2.72 0.04 Bn
211 IPHA Innate Pharma SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.06 60.09 0.17 Bn
212 ADCT ADC Therapeutics SA primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -1.15 2.25 -0.05 Bn
213 OKUR OnKure Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.17 Bn -2.66 — -0.01 Bn
214 INDP Indaptus Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -10.88 — 0.15 Bn
215 MOLN Molecular Partners Ag primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -2.42 190.84 0.16 Bn
216 MDWD MediWound Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.16 Bn -5.00 13.10 0.12 Bn
217 RANI Rani Therapeutics Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -4.71 31.72 0.15 Bn
218 NGEN Nervgen Pharma Corp. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -116.03 — 0.15 Bn
219 MIST Milestone Pharmaceuticals Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn — — -0.03 Bn
220 MSLE Satellos Bioscience Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.15 Bn -2.83 — 0.15 Bn
221 UNCY Unicycive Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -5.17 — 0.14 Bn
222 ENTX Entera Bio Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn -9.77 — 0.13 Bn
223 IFRX InflaRx N.V. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.14 Bn 0.00 1,741.29 -0.05 Bn
224 SPRB Spruce Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -2.76 — 0.13 Bn
225 HURA TuHURA Biosciences, Inc./NV primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -4.24 — 0.13 Bn
226 NRXP NRX Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -6.10 37.42 0.10 Bn
227 IBIO iBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -3.85 1,269.53 0.13 Bn
228 CNTB Connect Biopharma Holdings Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.13 Bn -1.83 42.80 0.13 Bn
229 RFL Rafael Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -4.65 126.51 0.12 Bn
230 PMN ProMIS Neurosciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.12 Bn -2.86 — 0.07 Bn
231 TLSA Tiziana Life Sciences Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -6.55 — 0.11 Bn
232 BDTX Black Diamond Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -2.33 — 0.00 Bn
233 GNLX GENELUX Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -3.21 — 0.11 Bn
234 INO Inovio Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -1.36 — 0.11 Bn
235 COYA Coya Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.11 Bn -4.74 13.18 0.06 Bn
236 CRBP Corbus Pharmaceuticals Holdings, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn — — -0.06 Bn
237 PLYX Polaryx Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn -9.77 — 0.09 Bn
238 RLYB Rallybio Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.10 Bn 2.13 150.51 0.10 Bn
239 CTOR Citius Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -2.06 60.89 0.09 Bn
240 ONCY Oncolytics Biotech Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.06 — 0.09 Bn
241 TLPH Talphera, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -6.52 92,142.82 0.09 Bn
242 OTLK Outlook Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -1.46 — 0.08 Bn
243 ALDX Aldeyra Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -3.85 — 0.09 Bn
244 RVRC Revium Rx. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.09 Bn -118.64 — 0.09 Bn
245 ACRV Acrivon Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.15 — 0.08 Bn
246 PYPD PolyPid Ltd. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 2.68 — 0.08 Bn
247 KZIA Kazia Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn — — 0.08 Bn
248 FBIO Fortress Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn 9.72 1.18 -0.12 Bn
249 KLRS Kalaris Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.67 — 0.08 Bn
250 MAIA MAIA Biotechnology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -2.97 — 0.05 Bn
251 CRDF Cardiff Oncology, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.08 Bn -1.86 132.02 0.08 Bn
252 GANX Gain Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -4.02 — 0.07 Bn
253 ATHE Alterity Therapeutics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 0.00 — 0.07 Bn
254 TELO Telomir Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.48 — 0.07 Bn
255 XBIT XBiotech Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.59 — 0.07 Bn
256 SPRO Spero Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn 11.32 1.40 0.01 Bn
257 DWTX Dogwood Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.07 Bn -1.82 — 0.07 Bn
258 HRTX Heron Therapeutics, Inc. /De/ primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -6.86 0.40 0.02 Bn
259 ALGS Aligos Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.06 Bn -0.79 14.88 0.03 Bn
260 SCYX Scynexis Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -3.04 2.86 -0.06 Bn
261 RNTX Rein Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.05 — 0.05 Bn
262 IBO Impact Biomedical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -2.73 1,467.60 0.05 Bn
263 TIL Instil Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.24 — 0.05 Bn
264 NMAD Nomad Power Solutions, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.25 — 0.05 Bn
265 MCRB Seres Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.60 26.24 0.05 Bn
266 IMMP IMMUTEP Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -0.40 5.09 0.05 Bn
267 HOWL Werewolf Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -1.41 2.28 0.05 Bn
268 PTN Palatin Technologies Inc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -7.52 3.66 0.05 Bn
269 BDRX Biodexa Pharmaceuticals Plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.05 Bn -6.38 — 0.03 Bn
270 IMA ImageneBio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn — — -0.09 Bn
271 EDSA Edesa Biotech, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -4.38 — 0.04 Bn
272 NXTC NextCure, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.97 — 0.04 Bn
273 ATYR aTYR PHARMA INC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.66 294.15 -0.02 Bn
274 ELTX Elicio Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.04 — 0.02 Bn
275 ATNM Actinium Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn 3.53 1.14 0.04 Bn
276 MREO Mereo BioPharma Group plc primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.03 79.26 0.04 Bn
277 SER Serina Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.38 300.10 0.02 Bn
278 FLNA Filana Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -1.60 — 0.04 Bn
279 LITS Lite Strategy, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.04 Bn -0.66 — 0.03 Bn
280 CNTX Context Therapeutics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.75 — 0.03 Bn
281 APLM Apollomics Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.72 4.79 0.03 Bn
282 ALP Alpha Compute Corp primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.02 0.19 0.03 Bn
283 BHST Bioharvest Sciences Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.16 0.95 0.02 Bn
284 KYNB Kyntra Bio, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn 0.16 4.24 0.03 Bn
285 KAPA Kairos Pharma, LTD. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -6.19 0.38 0.03 Bn
286 BETRF BetterLife Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -21.49 — 0.03 Bn
287 BRNS Barinthus Biotherapeutics plc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.74 — 0.03 Bn
288 TAOX TAO Synergies Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.32 37.58 0.03 Bn
289 CLRB Cellectar Biosciences, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -1.24 — 0.03 Bn
290 ADIL Adial Pharmaceuticals, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -0.46 — 0.03 Bn
291 RAPH Raphael Pharmaceutical Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -23.02 — 0.03 Bn
292 IGC IGC Pharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -12.26 93.50 0.03 Bn
293 ABVC Abvc Biopharma, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn -3.59 — 0.03 Bn
294 YDESW YD Bio Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.03 Bn — — 0.02 Bn
295 VRXA Veraxa Biotech AG - Post de-SPAC primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.30 869.19 0.02 Bn
296 RDPTF Radiopharm Theranostics Ltd primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.28 97.58 0.02 Bn
297 NNVC Nanoviricides, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.74 — 0.02 Bn
298 LTRN Lantern Pharma Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -1.44 — 0.02 Bn
299 JSPR Jasper Therapeutics, Inc. primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -0.10 — 0.02 Bn
300 EVAX Evaxion A/S primary H-02 Pharmaceuticals and Biotechnology HG-01 0.02 Bn -2.31 2.67 0.01 Bn